Substitutions of codon 306 in the gene embB are the most common mutations found in ethambutol resistant Mycobacterium tuberculosis. The characterization of these mutations has been hampered by the need for prior cultivation of the mycobacteria, or the need for DNA sequencing, or both. Here, we describe a simple and culture-independent technique to detect embB codon 306 mutations directly from sputum samples, requiring little more than a PCR machine and a simple agarose minigel. There is no need for labelled probes or DNA sequencing. In a preliminary test of feasibility, interpretable results were obtained from 21 of 24 selected sputum samples, 12 of which were determined to contain ethambutol resistant M. tuberculosis after culture. All of six samples with embB codon 306 mutations were correctly identified. Although an exact validation of this technique is beyond the scope of this technical report, we conclude from well-known embB codon 306 mutation prevalence figures that approximately one half of EMB resistant cases could already be predicted within 2 working days, with little equipment or hands-on time needed, instead of weeks required for conventional resistance testing.
INTRODUCTION
In the majority of cases, resistance to EMB is associated to resistances to other anti-tuberculosis Ethambutol (EMB) is a first-line drug in the therapy drugs. 1 Therefore, an early detection of EMB resistance would not only abolish risks of adverse reactions, of tuberculosis. Combined with isoniazid (INH), rifampicin, and pyrazinamide, it is recommended as particularly optic neuritis, of an actually ineffective EMB treatment, but it would also give a strong inan alternative to streptomycin as a fourth drug during the initial phase of therapy until susceptibilities are dication for the need for a modification of the therapy regimen. known, unless the patient has no individual risk factors for drug resistance and lives in an area where It is unfortunate that the median times (and average times must be expected to be even longer) needed primary INH resistance is below 4%. for cultivation and susceptibility testing has been Jolla, CA, USA) and eluted into 100 l Tris-buffer (10 m Tris-HCl, pH 8·3). reported to be between 21 and 60 days, depending on the methods used. 2 If the initial therapeutic regimen is proven ineffective, that time not only increases the Primer construction and nested PCR time the patient remains infective with a drug resistant strain, but it is also lost for the patient. The early start
The outer primers MYC-44 (5′-CGT CTA GAT CGC of an effective therapy with at least two drugs to GTT GTG GCG CCT-3′) and MYC-45 (5′-CGC TGC which the strain is susceptible is a key requirement AGT CCA CAG ACT GGC GTC GC-3′) and the inner for a positive treatment outcome in multidrug-resistant primers MYC-46 (5′-CTG CTC TGG CAT GTC AT-3′) tuberculosis. 3, 4 and MYC-47 (5′-AGC GGA AAT AGT TGG AC-3′) The application of molecular methods for the were constructed to asymmetrically encompass detection of genomic mutations indicative of drug codon 306 (ATG) which overlaps with an NlaIII reresistance have been suggested to accelerate reporting striction enzyme site (CATG). The inner primers were times, but they are not widely used because they either targeted close to the next neighbouring NlaIII sites, require specialized equipment, or are expensive, or located 44 bp upstream and 30 bp downstream, in both. In this report, we describe a low-cost, loworder to avoid additional restriction products that technology approach to detect, directly from sputum might interfere with the subsequent restriction fragsamples, the most frequently found mutation in EMB ment length polymorphism (RFLP) analysis. The PCR resistant Mycobacterium tuberculosis, a substitution reactions were done employing a 'hot start' technique in codon 306 of the gene embB.
in which 3 l of the DNA eluate and 38·2 l water (or 2 l of the first PCR and 39·4 l water for the second, nested PCR) were heated to 96°C for 2 min MATERIALS AND METHODS after the addition of 1 l each of 50 m solutions of the primers, 0·8 l (first PCR) or 0·6 l (nested PCR) Sputum samples and DNA isolation of 50 m MgCl 2 , and two drops of mineral oil. After cooling to 85°C, 6 l of a freshly prepared mixture of A total of 24 sputum samples were collected from 24 5 l buffer (100 m Tris-HCl, pH 8·3, 500 m KCl), patients from Germany (no. 1-4 and 21-22) , Italy 0·5 l of dNTP-mix (25 m each) and 0·5 l (5 u/ l) (no. 5-11 and 23-24) , , and Spain of Taq DNA polymerase was added. For both the first (no. 19-20) , known or suspected to be infected with and the nested PCR, the most sensitive signal-to-EMB resistant M. tuberculosis ( Table 1 ). The samples background relation was observed after 50 cycles were processed as for routine culture preparations by each of denaturation at 92°C for 60 s, annealing at shaking 20 min at room temperature with an equal 48°C (first PCR) or 46°C (nested PCR) for 60 s, and volume of decontaminating solution (2% (w/v) NaOH, extension at 72°C for 60 s. 1·5% (w/v) sodium citrate, 5 g/l N-acetyl--cysteine). After adjusting the volume to 50 ml with phosphate buffer (35·6 m KH 2 PO 4 , 31·1 m Na 2 HPO 4 ·2H 2 O, Restriction endonuclease digests pH 6·8) the suspension was centrifuged at 3500 g for 20 min and the pellet was resuspended in 1 ml Four microlitres of the nested PCR reaction, 4 l water, phosphate buffer. Approximately half of this material 1 l of digestion buffer (Nr. 4; New England Biolabs), was used for microscopy and cultures. After growth, and 1 l (10 u/ l) of NlaIII were incubated at 37°C susceptibility testing was performed by the 1% profor 90 min. Alternatively, very faint PCR products portion method (DIN 58943, part 8). All EMB resistant could still be analysed after silica gel adsorption of isolates were resistant at a level of at least 1 g/ml the remaining PCR product either directly from the EMB. The other half of the decontaminated myco-PCR product, or from the 103-bp band following bacterial suspension was heated to 80°C or higher electrophoresis and excision from a 2·5% (w/v) agarfor at least 10 min before mailing it to the PCR ose gel containing 0·2 g/ml ethidium bromide, and laboratory. There, the suspension was pelleted in a elution into 8 l of TE buffer. The latter would also microcentrifuge for 2 min, resuspended in 100 l 1  be an option if excessive primer-dimer formation was NaOH, 2% (v/v) Triton X-100, boiled for 5 min and observed which could later interfere with the RFLP neutralized with 100 l unbuffered 1  Tris-HCl. 5 After pattern. Restriction products were visualized in a 3% pelleting debris in a microcentrifuge for 3 min the (w/v) agarose gel in TAE buffer (40 m Tris-acetate DNA in the aqueous phase was adsorbed to 5 l of (pH 8·5); 1 m EDTA) containing 0·2 g/ml ethidium bromide. The agarose is best dissolved on a hot plate a silica gel suspension ('Geneclean'; BIO 101, La with an integrated magnetic stirrer in an Erlenmeyer OH, USA). When there was not enough DNA for direct sequencing or when direct sequencing gave flask with a smaller, inverted flask on top to reduce evaporation. As the solution becomes more viscous, ambiguous results, the second, nested PCR was repeated with primers MYC-46A (5′-CGT CTA GAC the stirrer speed should be increased as much as possible, but without squirting. The hot plate should TGC TCT GGC ATG TCA T-3′) and MYC-47A (5′-CGC TGC AGC GGA AAT AGT TGG AC-3′), conbe turned off early enough to allow only a short final boiling of the then clear solution. The ethidium taining XbaI and PstI linkers, respectively. The products were ligated into pBluescript II SK − vectors bromide is added to the cooled solution just before pouring the gel.
(Stratagene, La Jolla, CA, USA), and the constructs were then used to transform XL1-Blue cells (Stratagene) in order to generate plasmid templates for sequencing.
DNA cloning and sequencing
For direct sequencing, the PCR products were excised from the agarose gel. The DNA was then purified by RESULTS silica gel adsorption, eluted with 8 l of TE buffer, and 7 l of this solution were heated with 1 l (5 M)
Nested PCR reactions on DNA with and without embB codon 306 substitutions gave PCR products of of the primer MYC-46 in a boiling water bath for 5 min. After heating, the solution was snap-frozen in the expected, identical sizes of 0·1 kb (Fig. 1) . Two of 21 smear-positive, and 1 of 3 smear-negative dry ice/ethanol, and the regular sequencing protocol was followed thereafter using a Sequenase 2.0 kit samples did not yield PCR products (Table 1) . After NlaIII digestion, DNA from all of 11 sputum samples (United States Biochemical Corporation, Cleveland, subsequently determined to contain EMB sensitive The 6 samples lacking digestion products in the range of 0·03 kb to 0·04 kb (no. 5, 7, 8, 17, 21 and 24) M. tuberculosis which also yielded a PCR product, and DNA from four samples with EMB resistant contained substitutions of the wild-type codon 306 ATG (Met) to GTG (Val) in four isolates, and to ATC M. tuberculosis showed products in the range of 0·03 kb to 0·04 kb, while 6 sputum samples, all of or to ATA (both Ile) in the remaining two samples. them determined to contain EMB resistant M. tuberculosis after culture, lacked these bands (no. 5, 7, 8, 17, 21 and 24, Fig. 1) . DISCUSSION An internal control of the authenticity of the PCR product and of the completeness of the digestion are Only recently, the emb locus was discovered as the drug target for EMB, first in M. avium. 6 Then, the invariant 11-bp and 18-bp products from both mutated and wild-type sequences (Fig. 2) . Therefore, substitutions of codon 306 in the M. tuberculosis gene embB were shown to be the most frequent and even in samples with the mutated genotype which have lost the NlaIII site overlapping codon 306, there most predictive mutations for EMB resistance. 7 In the two largest studies to date, this codon was found to is a visible reduction in the size of the PCR product compared to that of the original product, which can be mutated in 39 of 67 (58%) and in 13 of 28 (46%) EMB resistant isolates, but not in 28 and 44 EMB be seen even if the 11-bp and 18-bp products themselves are too faint to be visible (Fig. 1) . The wildsensitive isolates. 7, 8 The described PCR-RFLP technique takes advantage of the fact that the recognition type sequence will give two additional products of 30 bp and 44 bp (Fig. 2) . The best diagnostic aid to site of the endonuclease NlaIII (CATG) overlaps completely with the wild-type embB codon 306 DNA predict EMB resistance is the absence of products in the range of 0·03-0·04 kb.
sequence (ATG). Therefore, any mutation of this codon will lead to a loss of the NlaIII site. The results of the restriction enzyme digestions were confirmed by sequencing in all cases ( Table 1) .
The technique also allows the detection of mixed populations of the resistant as well as the sensitive effective therapy regimen, but also because of the possibility for rapid intervention strategies in an effort genotype within the same specimen. An example for this is sample no. 23 (Fig. 1) . A partial digestion as to limit transmissions. It is unfortunate that examples from other resistance genes show that despite its an explanation can be ruled out, because the internal control, as explained in the results, does not show potential, genotypic analysis has not yet found a wide use in routine diagnostic laboratories. One reason for any undigested 103-bp PCR product. The finding is much rather compatible with a, thus far, little studied this is that some protocols are dependent on cultured mycobacteria for DNA preparations, thereby minphenomenon called heteroresistance. 9 The term describes a mixed population of resistant and sensitive imizing the actual amount of time saved because 2/3 to 3/4 of the time is needed for the initial cul-M. tuberculosis, which would also result in the simultaneous generation of 74-bp, 44-bp and 30-bp protivation. Others require specialized equipment and expertise, for example DNA sequencing and singleducts. It is yet unclear how heteroresistance detected in the sputum sample affects the subsequent phenostrand conformation polymorphism analysis. Yet another aspect is the basic cost per sample, which can typic susceptibility testing after cultivation. Therefore, the safest diagnostic criterion to predict EMB rebe as high as US$ 35.00 for rifampicin resistance testing using a commercial kit (Innogenetics INNOsistance is the absence of 30-bp and 44-bp digestion products in samples predicted to be EMB resistant.
LiPA RifTB). The basic cost per sample for PCR plus sequencing has been estimated at US$ 10.00, while As with any other genotype-based resistance prediction test, a limitation in characterizing embB codon PCR and electrophoresis cost US$ 1.50 to 3.00. 10 It is therefore not surprising that an 'immediate need' 306 mutations is that no prediction can be made for samples containing the unmutated genotype, both in has been ascertained to develop rapid, simple, and accurate assays to assess M. tuberculosis DNA polyisolation and in mixed populations. The wild-type genotype could either come from EMB sensitive cells, morphisms.
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The presented PCR-RFLP method using the reor from those EMB resistant organisms that do not carry this mutation. The diagnostic categories are striction enzyme NlaIII is both simple and rapid.
Results of a preliminary study on a test panel of therefore not 'resistant' and 'sensitive', but resistant and 'no prediction possible'. For this reason, it is up 24 sputum samples, in comparison with phenotypic resistance determinations and genotypic analysis by to debate if or when a rapid resistance prediction test with high specificity but low sensitivity is useful. The DNA sequencing, indicated accuracy, too. All of six samples with phenotypically EMB resistant answer may depend on the alternative, which is having to wait for weeks to detect ethambutol re-M. tuberculosis and mutations in embB codon 306, as determined by DNA sequencing, were correctly sistance by culture in all affected patients rather than detecting half of these cases within 2 days. The identified. We estimate the basic costs per sample at less than US$ 5.00, including 5 U Taq polymerase, difference between the two options may be substantial not only for the individual patient with respect to 10 U NlaIII, and other consumables. The test can be done within 2 working days with a minimum of actual potential adverse reactions to an unnecessarily given drug as well as the benefit of a timely start of a more hands-on time.
